Nine Ten Capital Management Lowers stake in Mesa Laboratories (MLAB)

Mesa Laboratories (MLAB) : Nine Ten Capital Management reduced its stake in Mesa Laboratories by 8.12% during the most recent quarter end. The investment management company now holds a total of 253,861 shares of Mesa Laboratories which is valued at $26,256,843 after selling 22,422 shares in Mesa Laboratories , the firm said in a disclosure report filed with the SEC on Aug 10, 2016.Mesa Laboratories makes up approximately 9.16% of Nine Ten Capital Management’s portfolio.

Other Hedge Funds, Including , Blackrock Institutional Trust Company N.a. boosted its stake in MLAB in the latest quarter, The investment management firm added 8,993 additional shares and now holds a total of 42,926 shares of Mesa Laboratories which is valued at $4,439,836.Royce Associates Lp reduced its stake in MLAB by selling 5,100 shares or 8.63% in the most recent quarter. The Hedge Fund company now holds 54,000 shares of MLAB which is valued at $5,654,880. Mesa Laboratories makes up approx 0.04% of Royce Associates Lp’s portfolio. Gsa Capital Partners Llp sold out all of its stake in MLAB during the most recent quarter. The investment firm sold 2,110 shares of MLAB which is valued $226,361. Quantbot Technologies Lp added MLAB to its portfolio by purchasing 55 company shares during the most recent quarter which is valued at $5,782.Rice Hall James Associates reduced its stake in MLAB by selling 579 shares or 2.15% in the most recent quarter. The Hedge Fund company now holds 26,313 shares of MLAB which is valued at $3,179,926. Mesa Laboratories makes up approx 0.17% of Rice Hall James Associates’s portfolio.

Mesa Laboratories opened for trading at $102.95 and hit $104.55 on the upside on Friday, eventually ending the session at $104.45, with a gain of 1.27% or 1.31 points. The heightened volatility saw the trading volume jump to 6,954 shares. Company has a market cap of $383 M.

Investors should note that on Jul 6, 2016, Mesa Laboratories announced a cash dividend of $0.1600. The company’s management has announced Aug 29, 2016 as the ex-dividend date and fixed the record date on Aug 31, 2016. The payable date has been fixed on Sep 15, 2016.

Many Wall Street Analysts have commented on Mesa Laboratories. Mesa Laboratories was Downgraded by Sidoti to ” Neutral” on Jun 10, 2016.

Mesa Laboratories Inc. is primarily focused on quality control products. The Company has three segments: Instruments Biological Indicators and Continuous Monitoring. The Company’s Instruments segment designs manufactures and markets quality control instruments and disposable products utilized in connection with the healthcare pharmaceutical food and beverage medical device industrial hygiene environmental air sampling and semiconductor industries. Its Biological Indicators segment manufactures and markets biological indicators and distributes chemical indicators used to assess the effectiveness of sterilization processes in the hospital dental medical device and pharmaceutical industries. Its Continuous Monitoring segment designs develops and markets systems which are used to monitor various environmental parameters in hospitals pharmaceutical and medical device manufacturers blood banks pharmacies and a number of other laboratory and industrial environments.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *